Raymond James & Associates’s Alcentra Capital Corp ABDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-46,253
Closed -$419K 3840
2019
Q4
$419K Buy
46,253
+2,504
+6% +$22.5K ﹤0.01% 2860
2019
Q3
$389K Sell
43,749
-5,236
-11% -$45.2K ﹤0.01% 2835
2019
Q2
$410K Buy
48,985
+2,558
+6% +$21.1K ﹤0.01% 2814
2019
Q1
$348K Sell
46,427
-3,489
-7% -$25.2K ﹤0.01% 2897
2018
Q4
$323K Sell
49,916
-3,049
-6% -$19K ﹤0.01% 2821
2018
Q3
$317K Sell
52,965
-33,799
-39% -$211K ﹤0.01% 2987
2018
Q2
$554K Sell
86,764
-23,249
-21% -$155K ﹤0.01% 2605
2018
Q1
$766K Sell
110,013
-36,841
-25% -$284K ﹤0.01% 2303
2017
Q4
$1.23M Sell
146,854
-101,673
-41% -$905K ﹤0.01% 2004
2017
Q3
$2.66M Sell
248,527
-53,050
-18% -$607K 0.01% 1451
2017
Q2
$4.1M Buy
301,577
+72,420
+32% +$998K 0.01% 1124
2017
Q1
$3.15M Buy
229,157
+36,508
+19% +$464K 0.01% 1259
2016
Q4
$2.31M Buy
192,649
+19,389
+11% +$240K 0.01% 1399
2016
Q3
$2.25M Buy
173,260
+6,500
+4% +$81.3K 0.01% 1376
2016
Q2
$2.03M Buy
166,760
+26,517
+19% +$315K 0.01% 1323
2016
Q1
$1.63M Buy
140,243
+15,613
+13% +$163K 0.01% 1400
2015
Q4
$1.45M Buy
124,630
+5,356
+4% +$64K 0.01% 1434
2015
Q3
$1.38M Buy
119,274
+1,305
+1% +$16.4K 0.01% 1428
2015
Q2
$1.5M Buy
117,969
+29,350
+33% +$404K 0.01% 1500
2015
Q1
$1.18M Buy
88,619
+15,486
+21% +$208K 0.01% 1561
2014
Q4
$914K Buy
73,133
+15,948
+28% +$202K ﹤0.01% 1627
2014
Q3
$759K Sell
57,185
-64,215
-53% -$874K ﹤0.01% 1654
2014
Q2
$1.8M Buy
+121,400
New +$1.79M 0.01% 1151

Raymond James & Associates's ABDC Position: Q1 2020 in Review

Raymond James & Associates sold out of Alcentra Capital Corp (ABDC) in Q1 2020, closing a stake of 46,253 shares — an estimated $419K sold.

Raymond James & Associates first reported a position in ABDC in Q2 2014 and held it in 23 quarters. The position peaked at $4.1M in Q2 2017. 0 funds tracked by Wall St. Rank hold ABDC as of Q1 2020.

  • Raymond James & Associates reported no remaining Alcentra Capital Corp position as of Q1 2020 after selling out during the quarter.
  • Raymond James & Associates sold 46,253 Alcentra Capital Corp shares in Q1 2020, an estimated $419K.
  • Raymond James & Associates first reported a position in Alcentra Capital Corp in Q2 2014 and held it in 23 quarters.
  • Raymond James & Associates's Alcentra Capital Corp position peaked at $4.1M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Alcentra Capital Corp as of Q1 2020.

Based on Raymond James & Associates's 13F filing for Q1 2020, filed 21 Apr 2020.